Bulur, I. Et Al. 2018. The efficacy and safety of omalizumab in refractory chronic spontaneous urticaria: real-life experience in Turkey. ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA , vol.27, no.3 , 121-126.

Bulur, I., BÜLBÜL BAŞKAN, E., Ozdemir, M., Balevi, A., Goncu, E. K., Altunay, I., ... Gonul, M.(2018). The efficacy and safety of omalizumab in refractory chronic spontaneous urticaria: real-life experience in Turkey. ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA , vol.27, no.3, 121-126.

Bulur, Isil Et Al. "The efficacy and safety of omalizumab in refractory chronic spontaneous urticaria: real-life experience in Turkey," ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA , vol.27, no.3, 121-126, 2018

Bulur, Isil Et Al. "The efficacy and safety of omalizumab in refractory chronic spontaneous urticaria: real-life experience in Turkey." ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA , vol.27, no.3, pp.121-126, 2018

Bulur, I. Et Al. (2018) . "The efficacy and safety of omalizumab in refractory chronic spontaneous urticaria: real-life experience in Turkey." ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA , vol.27, no.3, pp.121-126.

@article{article, author={Isil Bulur Et Al. }, title={The efficacy and safety of omalizumab in refractory chronic spontaneous urticaria: real-life experience in Turkey}, journal={ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA}, year=2018, pages={121-126} }